ResMed (RMD) News Today

ResMed (NYSE:RMD) Trading Down 3.1%

Natixis lowered its position in ResMed Inc. (NYSE:RMD - Free Report) by 17.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,055 shares of the medical equipment provider's stock after selling 2,937 sh

American International Group Inc. decreased its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 6.3% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,428 shares of the medical equipment provider's s

ResMed (NYSE:RMD) will be releasing earnings after the market closes on Thursday, August 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=606257)

UniSuper Management Pty Ltd increased its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 9.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,100 shares of the medical equipment provider's

Vanguard Group Inc. raised its position in ResMed Inc. (NYSE:RMD - Free Report) by 0.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,769,766 shares of the medical equipment provider's stock after acquiring an add

Mitsubishi UFJ Trust & Banking Corp cut its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 3.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 96,138 shares of the medical equipment provider's stock

Twin Tree Management LP lowered its stake in ResMed Inc. (NYSE:RMD - Free Report) by 67.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,946 shares of the medical equipment provider'

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 24.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 177,083 shares of the medical equipment p

Entropy Technologies LP lowered its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 84.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,082 shares of the medical equipment provider's stock after selling 16,988 shar

Shares of ResMed Inc. (NYSE:RMD - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eleven analysts that are covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommend

Swiss National Bank lowered its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 4.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 440,500 shares of the medical equipment provider's stock after selling 19,400 shares during the quarter. Swis

Susquehanna Fundamental Investments LLC purchased a new stake in ResMed Inc. (NYSE:RMD - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 7,300 shares of the medical equipment provider's sto

Mediolanum International Funds Ltd bought a new position in shares of ResMed Inc. (NYSE:RMD - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 11,438 shares of the medical equipment provider's stock, valued at appr

ResMed Inc. (NYSE:RMD - Get Free Report) CEO Michael J. Farrell sold 14,683 shares of the firm's stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $192.97, for a total value of $2,833,378.51. Following the sale, the chief executive officer now directly owns 440,799 shares in the company, valued at approximately $85,060,983.03. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

ResMed Inc. (NYSE:RMD - Get Free Report) CFO Brett Sandercock sold 1,000 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of $194.35, for a total value of $194,350.00. Following the sale, the chief financial officer now owns 90,056 shares in the company, valued at $17,502,383.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Nordea Investment Management AB increased its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 1,844.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 189,652 shares of the medical e

Daiwa Securities Group Inc. lifted its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 28.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,344 shares of the medical equ

Janney Montgomery Scott LLC grew its stake in ResMed Inc. (NYSE:RMD - Free Report) by 5.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 81,313 shares of the medical equipment provider's stock after buying an add

Norden Group LLC boosted its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 3,620.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,080 shares of the medical equipment provider's stock af

Congress Wealth Management LLC DE boosted its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 11.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 63,403 shares of the medical equipment provider's stock after buying an additional 6

ResMed Inc. (NYSE:RMD - Free Report) - Zacks Research lifted their FY2024 EPS estimates for ResMed in a note issued to investors on Thursday, June 27th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will post earnings per share of $7.60 for the year, up

ResMed Inc. (NYSE:RMD - Get Free Report) was the target of a large drop in short interest during the month of June. As of June 15th, there was short interest totalling 8,240,000 shares, a drop of 16.5% from the May 31st total of 9,870,000 shares. Based on an average daily trading volume, of 1,130,000 shares, the short-interest ratio is currently 7.3 days.

Wellington Management Group LLP bought a new stake in shares of ResMed Inc. (NYSE:RMD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 43,804 shares of the medical equipment provider's stoc

Oppenheimer cut ResMed from an "outperform" rating to a "market perform" rating in a research note on Tuesday.

Needham & Company LLC reaffirmed a "buy" rating and issued a $236.00 price target on shares of ResMed in a research note on Monday.

ResMed Inc. (NYSE:RMD - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the ten ratings firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year t

Congress Asset Management Co. MA boosted its position in ResMed Inc. (NYSE:RMD - Free Report) by 1.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 584,210 shares of the medical equipment provider's stock after purchasing a

Massmutual Trust Co. FSB ADV boosted its position in ResMed Inc. (NYSE:RMD - Free Report) by 22.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 59,751 shares of the medical equipment provider's stock after

Los Angeles Capital Management LLC lifted its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 3,599.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 499,031 shares of the medical equipment provider's stock

Confluence Investment Management LLC purchased a new stake in ResMed Inc. (NYSE:RMD - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 129,161 shares of the medical equipment

Vanguard Group Inc. lifted its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,743,457 shares of the medical equipmen

Congress Asset Management Co. MA grew its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 9.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 577,979 shares of the medical equipment provider's stock after acquiring

Greenvale Capital LLP raised its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 198.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 551,901 shares of the medical equipment provider's stock